Collectively, these studies provided evidence that the observed cytotoxicity is most likely the result of intracellular GGPP depletion, and supported the hypothesis that direct inhibition of GGPPS could be a more logical and effective mechanism for the treatment of various leukemias, including AML. The gene discussed is GGPS1; the disease is acute myeloid leukemia.